IE36653B1 - 17-hydroxy-7-(lower alkoxy) carbonyl-3-oxo-17alpha-pregn-4-ene-21-carboxylic acidgamma-lactones and congeners - Google Patents

17-hydroxy-7-(lower alkoxy) carbonyl-3-oxo-17alpha-pregn-4-ene-21-carboxylic acidgamma-lactones and congeners

Info

Publication number
IE36653B1
IE36653B1 IE1160/72A IE116072A IE36653B1 IE 36653 B1 IE36653 B1 IE 36653B1 IE 1160/72 A IE1160/72 A IE 1160/72A IE 116072 A IE116072 A IE 116072A IE 36653 B1 IE36653 B1 IE 36653B1
Authority
IE
Ireland
Prior art keywords
compound
alkyl
give
contacting
oxo
Prior art date
Application number
IE1160/72A
Other versions
IE36653L (en
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of IE36653L publication Critical patent/IE36653L/en
Publication of IE36653B1 publication Critical patent/IE36653B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001Lactones
    • C07J21/003Lactones at position 17

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

1368005 7-Carboxy steroids and related compounds G D SEARLE & CO 24 Aug 1972 [25 Aug 1971] 39401/72 Heading C2U Novel steroids have the formulµ wherein Z is H, alkali metal, alkaline earth metal/2, ammonium or alkyl; Z<SP>1</SP> is H, alkali metal, alkaline earth metal/2 or ammonium when Z is alkyl and is identical to Z when Z is H, alkali metal, alkaline-earth metal/2 or ammonium; the #<SP>1</SP> double bond is optional; the wavy line indicates the alternative α and # configurations; and X is oxygen, and it may also be sulphur when Z is alkyl and #<SP>1</SP> is absent in (Ia). They are prepared by (a) contacting 4α,7α - carbonyl - 5 - cyano - 17 - hydroxy - 3- oxo - 5#,17α - pregnane - 21 - carboxylic acid γ-lactone with an alkali metal alkoxide to afford a mixture of 7α and 7# compounds (Ia) wherein X is O, Z is alkyl and #<SP>1</SP> is absent, which may be separated by conventional procedures; (b) contacting an active acylating derivative of a compound (Ia) wherein X is O and Z is H, particularly a novel compound of the formula with an alkanol to give compounds (Ia) wherein X is O and Z is alkyl, the acylating derivatives (II) being prepared from the corresponding 7- carboxylic acids (Ia) and alkyl chloroformates in the presence of a tertiary amine; (c) dehydrogenating a compound (Ia) wherein X is O, Z is alkyl and #<SP>1</SP> is absent to give the corresponding #<SP>1,4</SP> compound, using, for example, 2,3-dichloro - 5,6 - dicyano - 1,4 - benzoquinone; (d) reacting a compound (Ia) wherein X is O and Z is alkyl or H with, respectively, one or two equivalents of a base, e.g. KOH, in an aqueous medium, to give the corresponding mono- or bis-metal salt (Ib) followed, when required, by brief exposure to a proton source to give the corresponding mono- or di-carboxylic acid (Ib); (e) hydrolysing under alkaline conditions a compound (Ia) wherein X is O and Z is alkyl followed by mineral acid treatment to give a compound (Ia) wherein X is O and Z is H; (f) contacting a starting material as defined in (b) above with an alkane thiol to give a compound (Ia) wherein X is S, Z is alkyl and #<SP>1</SP> is absent; (g) contacting a starting material as defined in (a) above with KOH in methanol followed by alkaline hydrolysis and subsequent mineral acid treatment to give a corresponding 7α compound (Ia) wherein X is O, Z is H and #<SP>1</SP> is absent; (h) contacting a compound (Ia) or (Ib) wherein X is O, Z is H or alkyl and Z<SP>1</SP> is H which contains at least one acid hydrogen with an appropriate quantity of a base in an aqueous medium to give a corresponding mono- or bis-metal salt of a compound (Ia) or (Ib); or (i) contacting a compound (Ia) wherein X is O and Z is H or a compound (Ib) wherein X is O, Z is H or alkyl and Z<SP>1</SP> is H with excess ammonia to give a corresponding ammonium salt. 4α,7α - Carbonyl - 5 - cyano - 17 - hydroxy - 3- oxo - 5#,17α - pregnane - 21 - carboxylic acid γ-lactone is prepared by heating 17-hydroxy-3- oxo - 17α - pregna - 4,6 - diene - 21 - carboxylic acid γ-lactone with an alkali metal cyanide under slightly basic conditions in a solvent followed by heating the resulting 7α,4-aminomethylidyne - 5 - cyano - 17 - hydroxy - 3 - oxo- 5#,17α - pregnane - 21 - carboxylic acid γ- lactone with very dilute aqueous mineral acid (see Specification 1,368,006). The novel steroids of the Formulµ (Ia) and (Ib) are diuretic and blood pressure-lowering agents. They may be made up into pharmaceutical compositions with suitable carriers. [GB1368005A]
IE1160/72A 1971-08-25 1972-08-24 17-hydroxy-7-(lower alkoxy) carbonyl-3-oxo-17alpha-pregn-4-ene-21-carboxylic acidgamma-lactones and congeners IE36653B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17492271A 1971-08-25 1971-08-25

Publications (2)

Publication Number Publication Date
IE36653L IE36653L (en) 1973-02-25
IE36653B1 true IE36653B1 (en) 1977-01-19

Family

ID=22638078

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1160/72A IE36653B1 (en) 1971-08-25 1972-08-24 17-hydroxy-7-(lower alkoxy) carbonyl-3-oxo-17alpha-pregn-4-ene-21-carboxylic acidgamma-lactones and congeners

Country Status (21)

Country Link
JP (2) JPS5839840B2 (en)
AT (1) AT323907B (en)
AU (1) AU475957B2 (en)
BE (1) BE787940A (en)
CA (1) CA970361A (en)
CH (2) CH601350A5 (en)
DE (1) DE2241680C2 (en)
DK (1) DK133954B (en)
ES (2) ES406044A1 (en)
FI (1) FI50429C (en)
FR (1) FR2150852B1 (en)
GB (1) GB1368005A (en)
IE (1) IE36653B1 (en)
IL (1) IL40197A (en)
KE (1) KE2813A (en)
MY (1) MY7800121A (en)
NL (1) NL176569C (en)
NO (1) NO134990C (en)
PH (1) PH9271A (en)
SE (2) SE380533B (en)
ZA (1) ZA725839B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069219A (en) * 1976-12-27 1978-01-17 G. D. Searle & Co. 7ξ-(Alkoxycarbonyl)-6ξ-alkyl/halo-17-hydroxy-3-oxo-17α-pregn-4-ene-21-carboxylic acid γ-lactones and corresponding 21-carboxylic acids, their salts, and esters
FR2496669A1 (en) * 1980-12-23 1982-06-25 Roussel Uclaf NOVEL STEROID 3-KETO4 OR 1-4 SUBSTITUTED DERIVATIVES IN POSITION 7, PROCESS FOR PREPARING THEM AND THEIR APPLICATION AS MEDICAMENTS
DE3111951A1 (en) * 1981-03-23 1982-09-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen 7 (ALPHA) -ALKOXYCARBONYL-15SS-METHYLENE-4-ANDROSTENE, METHOD FOR THE PRODUCTION AND USE THEREOF AS A MEDICINAL PRODUCT
JPS57169230A (en) * 1981-04-10 1982-10-18 Matsushita Electric Ind Co Ltd Oil-immersed plastic ilm capacitor
US5296318A (en) * 1993-03-05 1994-03-22 Bell Communications Research, Inc. Rechargeable lithium intercalation battery with hybrid polymeric electrolyte
WO2006032970A2 (en) * 2004-09-09 2006-03-30 Pharmacia Corporation PROCESS FOR PREPARING 7α-ALKOXYCARBONYL SUBSTITUTED STEROIDS

Also Published As

Publication number Publication date
NL7211559A (en) 1973-02-27
NL176569B (en) 1984-12-03
KE2813A (en) 1978-02-10
AT323907B (en) 1975-08-11
SE7415187L (en) 1974-12-04
ES406044A1 (en) 1976-01-16
ZA725839B (en) 1973-10-31
MY7800121A (en) 1978-12-31
JPS5839840B2 (en) 1983-09-01
DK133954C (en) 1977-01-24
GB1368005A (en) 1974-09-25
NO134990B (en) 1976-10-11
CA970361A (en) 1975-07-01
CH601350A5 (en) 1978-07-14
IE36653L (en) 1973-02-25
IL40197A0 (en) 1972-10-29
DE2241680A1 (en) 1973-03-01
PH9271A (en) 1975-07-30
DE2241680C2 (en) 1982-09-09
FR2150852B1 (en) 1975-10-17
BE787940A (en) 1973-02-26
SE404024B (en) 1978-09-18
SE380533B (en) 1975-11-10
CH603689A5 (en) 1978-08-31
IL40197A (en) 1976-05-31
JPS4832860A (en) 1973-05-02
NL176569C (en) 1985-05-01
JPS5890598A (en) 1983-05-30
JPS611080B2 (en) 1986-01-13
FR2150852A1 (en) 1973-04-13
AU4578772A (en) 1974-02-28
DK133954B (en) 1976-08-16
AU475957B2 (en) 1976-09-09
FI50429C (en) 1976-03-10
ES435189A1 (en) 1976-12-01
NO134990C (en) 1977-01-26
FI50429B (en) 1975-12-01

Similar Documents

Publication Publication Date Title
IE36653B1 (en) 17-hydroxy-7-(lower alkoxy) carbonyl-3-oxo-17alpha-pregn-4-ene-21-carboxylic acidgamma-lactones and congeners
GB1371688A (en) Process for preparing benzoxazolones-2- and benzothiazolones-2
GB1147803A (en) Improvements in or relating to novel steroids and the manufacture thereof
GB1368006A (en) 4alpha,7alpha-carbonyl-5-cyano-17-hzydroxy-3-oxo-5beta,17alpha- pregnane-21-carboxylic acid ypsilon-lactone
GB1455220A (en)
GB1355991A (en) Unsaturated chemical compounds
GB1496169A (en) Stabilized polyglycol for high temperatures
GB1417808A (en) 7a-cyano-17-hydroxy-3-oxo-17a-pregn-4-ene-21-carboxylic acid ypsilon-lactone and related compounds
GB1130052A (en) Improvements in or relating to steroids and intermediates for the production thereof
GB1380952A (en) Cholestane derivatives and processes for their preparation
GB1074491A (en) Novel processes for preparing steroid compounds, the compounds when thus prepared, novel steroid compounds thereby prepared, and pharmaceutical compositions containing the novel compounds
GB1474142A (en) Lactone
GB1397434A (en) Evomonoside derivatives
GB1449914A (en) 2,2, 10beta, 17 alpha-tetramethyl steroids a process for their preparation and compositions containing them
GB1423028A (en) Acid calcium cis-epoxy-succinate and its production
GB1529249A (en) 21-acetals and mixed acetals of steroidal 21-aldehydes intermediates and methods of preparation
GB1466411A (en) Sulphur-containing hydroxy aliphatic compounds
GB1133713A (en) í¸-3-oxo-steroids
GB1512543A (en) Cholestane derivatives and their preparation
GB1388443A (en) Selective reduction of 9,15-dioxoprostanoic acids
GB1450693A (en) Beta-3-oxo-7alpha-acylthio-17beta-hydroxy-4-androsten-or estren- 17alpha-yl- propionic acidderivatives
JPS5272883A (en) Preparation of sulfur-containing amino acid
JPS5569563A (en) Preparation of 2-methoxy-5-sulfamoylbenzoic acid amide
GB1438100A (en) Cyclohexane derivatives and their use as odorants
GB1368731A (en) 9alpha 11alpha-epoxy spirolactones and corresponding spirolactols and lactol ethers